Oncology Business Management | Specialty

Developing Patient-Centered Medical Homes

November 14th 2012

Medical homes are physician-led healthcare teams that coordinate care for patients and typically rely on electronic methods for record-keeping, care coordination, and data collection.

FDA Grants Orphan Drug Status to Amatuximab for Malignant Pleural Mesothelioma

November 12th 2012

Amatuximab has received orphan drug status from the FDA to treat patients with malignant pleural mesothelioma, the most common form of mesothelioma.

Dr. Oh on Sequencing New Treatments for Prostate Cancer

November 12th 2012

William K. Oh, MD, from the Tisch Cancer Institute, discusses strategies for sequencing the new therapies that have been approved for treating castration-resistant prostate cancer.

How Can We Get Better Value in End-of-Life Care?

November 9th 2012

The last year of life is associated with high health expenditures in the United States, and the costs are increasingly focused on patients' last few months.

How Payers and Oncologists Really Feel About Clinical Pathways

November 6th 2012

Stakeholders weigh in on evidence-based pathway approach designed to decrease practice variation, improve outcomes, and reduce cost.

Which Practice Model Is Best for You?

October 31st 2012

Community oncologists must weigh multiple factors when deciding to consolidate or remain independent.

Management of Comorbidities in Early Breast Cancer

October 25th 2012

Novel Strategies for Treatment of Early Breast Cancer, Part II

October 25th 2012

Novel Strategies for Treatment of Early Breast Cancer, Part I

October 25th 2012

Anthracyclines for Early-Stage HER2-Positive Breast Cancer

October 25th 2012

Hormonal and HER2-Targeted Therapy in Early Breast Cancer

October 25th 2012

Potential Biomarker for Response to Bevacizumab in Colorectal Cancer Identified

October 25th 2012

Researchers have identified a potential predictive marker for survival in cases of metastatic colorectal cancer treated with bevacizumab.

Accountable Care Organizations Come to Oncology

October 17th 2012

Integrative model unites physicians, hospitals, and payers to deliver evidence-based care and control cancer costs.

Drug Shortages Frustrate Nurses and Jeopardize Patient Care

October 15th 2012

The promise of a solution somewhere on the horizon for America's drug shortages isn't enough for the registered nurse who navigates shortages every day.

FDA Approves Nab-Paclitaxel for Advanced Lung Cancer

October 12th 2012

The FDA has approved nab-paclitaxel plus carboplatin for patients with untreated locally advanced or metastatic NSCLC who are not candidates for surgery or radiation.

Dr. Petrylak on Enzalutamide's Role in Prostate Cancer

October 9th 2012

Daniel P. Petrylak, MD, from the Smilow Cancer Center, discusses the recent approval and future role of enzalutamide for patients with prostate cancer.

Oncologist Practice Consolidation Continues

October 9th 2012

Driven by changes in reimbursement and standards of care, independent community oncology practices continue to dwindle.

Are Physicians Drowning?

October 4th 2012

As with most industries where outcome metrics are crucial for continued success, the government is wanting physicians to deliver care that is outcome- and evidence-based.

Lessons on Patient Care Learned at Home

September 28th 2012

This fellow shares the insights he’s gained from his wife, a pediatric oncology nurse, and how they help in the care he provides.

Biomarker Predicts Survival Benefit in Advanced Kidney Cancer Treated With TORC1 Inhibitor

September 26th 2012

Pretreatment serum lactate dehydrogenase is a prognostic factor in poor-risk patients with renal cell carcinoma and also a predictive factor for a survival benefit from treatment with temsirolimus.